CTXR · Citius Pharmaceuticals, Inc.
$0.61
+0.04 (+6.45%)
At close · Aug 27
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We will need to raise additional capital in the future to support our operations beyond November 2026, which raises substantial doubt about the Company's ability to continue as a going concern within one year after the date that the accompanying consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$17.03M
Shares
27.45M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding CTXR
6 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND | — | 167,738 | $150,964 | 0.00% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 148,094 | $96,987 | 0.00% | Long | 2026-05-31 | |
| Direxion Low Priced Stock ETF | AAPD | 22,936 | $20,482 | 1.41% | Long | 2022-07-31 | |
| Fidelity Series Total Market Index Fund | — | 26,359 | $17,263 | 0.00% | Long | 2026-05-31 | |
| Fidelity Total Market Index Fund | — | 11,655 | $7,633 | 0.00% | Long | 2026-05-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 962 | $866 | 0.00% | Short | 2026-03-31 |
Showing 1–6 of 6 positions